Biolase Q3 EPS $(0.25) Misses $(0.13) Estimate, Sales $8.6M Miss $9.66M Estimate

Biolase (NASDAQ:BIOL) reported quarterly losses of $(0.25) per share which missed the analyst consensus estimate of $(0.13) by 92.31 percent. This is a 31.58 percent decrease over losses of $(0.19) per share from the

Benzinga · 11/06/2019 21:35

Biolase (NASDAQ:BIOL) reported quarterly losses of $(0.25) per share which missed the analyst consensus estimate of $(0.13) by 92.31 percent. This is a 31.58 percent decrease over losses of $(0.19) per share from the same period last year. The company reported quarterly sales of $8.6 million which missed the analyst consensus estimate of $9.66 million by 10.97 percent. This is a 21.36 percent decrease over sales of $10.936 million the same period last year.